Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG and NIRF in Minimally Invasive Paediatric Oncology Surgery
NCT04854018Phase 4Completed
- Sponsor
- Birmingham Women's and Children's NHS Foundation Trust
- Start
- Apr 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indocyanine green in renal tumor, osteosarcoma (OS), Ewing sarcoma, cancer, rhabdomyosarcoma (RMS), sponsored by Birmingham Women's and Children's NHS Foundation Trust. Started Apr 2021; status: completed.
02
Drugs
indocyanine green
03
Conditions
renal tumorosteosarcoma (OS)Ewing sarcomacancerrhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT04854018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04854018.